> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Izba Not Withdrawn for S&E
- URL: https://www.fdaweb.com/izba-not-withdrawn-for-s-e/
- Published: 2016-01-26T12:00:00.000Z
- Updated: 2026-09-15T02:30:40.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5134567

*Federal Register* Notice: FDA has determined that Izba (travoprost ophthalmic solution), 0.003 %, was not withdrawn from sale for reasons of safety or effectiveness. This determination will allow FDA to approve ANDAs for travoprost ophthalmic solution/drops, 0.003 %, if all other legal and regulatory requirements are met. To view this notice, click [here.](https://www.gpo.gov/fdsys/pkg/FR-2016-01-26/pdf/2016-01473.pdf?ref=fdaweb.com)